ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

URGN UroGen Pharma Ltd

14.30
0.04 (0.28%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
UroGen Pharma Ltd URGN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.04 0.28% 14.30 18:22:00
Open Price Low Price High Price Close Price Previous Close
14.50 14.14 14.70 14.30 14.26
more quote information »

Recent News

Date Time Source Heading
5/04/202414:20BWUroGen Announces Results from ATLAS Showing Robust UGN-102..
5/04/202410:50BWNew Real-World Study on Retrograde Instillation of JELMYTO®..
5/03/202407:00BWUroGen Pharma to Report 2024 First Quarter Financial Results..
4/17/202411:02BWUroGen Announces New Data Presentations at the American..
4/15/202407:00BWUroGen Announces FDA Acceptance of Investigational New Drug..
4/03/202407:00BWUroGen Pharma Files Patent Infringement Action Against Teva..
3/14/202407:00BWUroGen Pharma Delivers Double Digit JELMYTO® Growth and..
3/08/202407:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
3/04/202407:00BWUroGen Pharma to Report Fourth Quarter and Full-Year 2023..
3/04/202406:00EDGAR2Form 8-K - Current report
3/01/202406:00EDGAR2Form 8-K - Current report
2/26/202407:00BWUroGen Pharma to Present at TD Cowen 44th Annual Health Care..
2/12/202416:47EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
2/07/202415:15EDGAR2Form 8-K - Current report
2/02/202418:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202418:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202418:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202418:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/01/202409:13EDGAR2Form 144 - Report of proposed sale of securities
2/01/202408:53EDGAR2Form 144 - Report of proposed sale of securities
2/01/202407:00BWUroGen Pharma to Participate at Upcoming Investor..
1/24/202407:00BWUroGen Initiates Submission of a Rolling NDA to the FDA for..
1/17/202415:16EDGAR2Form 8-K - Current report
1/17/202407:00BWUroGen Secures Exclusive License from medac GmbH to Develop..
1/11/202407:00BWUroGen Pharma to Participate in the B. Riley Healthcare..
1/02/202407:04EDGAR2Form 8-K - Current report
12/08/202315:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
11/14/202315:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/14/202307:00BWUroGen Pharma Reports Third Quarter 2023 Financial Results
11/13/202307:00BWUroGen will Present Scientific Advances in Bladder Cancer at..
11/07/202307:00BWUroGen Pharma to Report Third Quarter 2023 Financial Results..
10/03/202307:00BWFollowing Pre-NDA Meeting with the FDA, UroGen Announces..
9/11/202315:15EDGAR2Form 8-K - Current report
9/11/202306:00GLOBEEledon Pharmaceuticals Appoints Industry Veteran James..
9/08/202315:16EDGAR2Form S-3 - Registration statement under Securities Act of..
9/08/202314:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202314:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202314:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202314:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202314:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202314:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202314:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/08/202307:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
9/05/202315:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/31/202307:00BWUroGen Pharma to Present at Upcoming Investor Conferences
8/10/202307:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202307:01EDGAR2Form 8-K - Current report
8/10/202307:00BWUroGen Pharma Reports Record JELMYTO Quarterly Sales and..
8/08/202307:00BWThe Journal of Urology Publishes Peer-Reviewed Article..
8/04/202307:56EDGAR2Form SC 13D - General statement of acquisition of beneficial..

Your Recent History

Delayed Upgrade Clock